{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:12:18Z","timestamp":1793383938891,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11307-022-01729-x","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T15:08:21Z","timestamp":1649689701000},"page":"789-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Comparison of 68Ga-FAPI PET\/CT and 18FDG PET\/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement"],"prefix":"10.1007","volume":"24","author":[{"given":"Umut","family":"Elboga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulay","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Burak","family":"Cayirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokmen","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Okuyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva Yesil","family":"Cinkir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Teker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem Nuray","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Aytekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latif","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayd\u0131n","family":"Aytekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Cimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Mumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benan","family":"Kilbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurtulus","family":"Eryilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davut","family":"Cakici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Zeki","family":"Celen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"2","key":"1729_CR1","first-page":"151","volume":"26","author":"MG Brizi","year":"2001","unstructured":"Brizi MG, Natale L, Manfredi R, Barbaro B, Vecchioli A, Marano P (2001) Staging of pancreatic ductal adenocarcinoma with spiral CT and MRI. Rays 26(2):151\u2013159","journal-title":"Rays"},{"key":"1729_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-007-9210-8","author":"RN Low","year":"2007","unstructured":"Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging. https:\/\/doi.org\/10.1007\/s00261-007-9210-8","journal-title":"Abdom Imaging"},{"key":"1729_CR3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.232025705","author":"L Kostakoglu","year":"2003","unstructured":"Kostakoglu L, Agress H Jr, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics. https:\/\/doi.org\/10.1148\/rg.232025705","journal-title":"Radiographics"},{"key":"1729_CR4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170519","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee SW (2018) Diagnostic accuracy of 18F-FDG PET\/CT for detection of peritoneal carcinomatosis: a systematic review and meta-analysis. Br J Radiol. https:\/\/doi.org\/10.1259\/bjr.20170519","journal-title":"Br J Radiol"},{"key":"1729_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1577-y","author":"A Suzuki","year":"2004","unstructured":"Suzuki A, Kawano T, Takahashi N, Lee J, Nakagami Y, Miyagi E et al (2004) Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-004-1577-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.08.006","author":"V Lopez-Lopez","year":"2016","unstructured":"Lopez-Lopez V, Cascales-Campos PA, Gil J, Frutos L, Andrade RJ, Fuster-Quinonero M et al (2016) Use of (18)F-FDG PET\/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2016.08.006","journal-title":"A pending issue Eur J Radiol"},{"key":"1729_CR7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.071001","author":"JD Soyka","year":"2010","unstructured":"Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A et al (2010) Influence of bowel preparation before 18F-FDG PET\/CT on physiologic 18F-FDG activity in the intestine. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.109.071001","journal-title":"J Nucl Med"},{"key":"1729_CR8","doi-asserted-by":"crossref","unstructured":"Zhao L,\u00a0Pang Y,\u00a0Luo Z,\u00a0Fu K,\u00a0Yang T,\u00a0Zhao L,\u00a0Sun L,\u00a0Wu H,\u00a0Lin Q, Chen\u00a0H. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT Eur J Nucl Med Mol Imaging. 2021;48:1944\u201355","DOI":"10.1007\/s00259-020-05146-6"},{"key":"1729_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. NatRevCancer. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"NatRevCancer"},{"key":"1729_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.12.5657","author":"MJ Scanlan","year":"1994","unstructured":"Scanlan MJ, Raj BK, Calvo B et al (1994) Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.91.12.5657","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1729_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","volume":"60","author":"A Loktev","year":"2019","unstructured":"Loktev A, Lindner T, Burger EM et al (2019) Development of novel FAP-targeted radiotracers with improved tumor retention. J Nucl Med 60:1421\u20131429","journal-title":"J Nucl Med"},{"key":"1729_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A et al (2018) Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med 59:1415\u20131422","journal-title":"J Nucl Med"},{"key":"1729_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-019-04444-y","volume":"46","author":"M R\u00f6hrich","year":"2019","unstructured":"R\u00f6hrich M, Loktev A, Wefers AK et al (2019) IDH-wildtypeglioblastomas and grade III\/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET\/CT. Eur J Nucl Med Mol Imaging 46:2569\u20132580","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s00259-019-04346-z","volume":"46","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Heussel CP, Lindner T et al (2019) FAPI-PET\/CT improves staging in a lung cancer patient with cerebral metastasis. Eur J Nucl Med Mol Imaging 46:1754\u20131755","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T et al (2019) 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAPI targeting agents in patients with various cancers. J Nucl Med 60:386\u2013392","journal-title":"J Nucl Med"},{"key":"1729_CR16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W et al (2018) A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med 59:1423\u20131429","journal-title":"J Nucl Med"},{"key":"1729_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T et al (2019) 8Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med 60:801\u2013805","journal-title":"J Nucl Med"},{"key":"1729_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04769-z","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J et al (2020) Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-04769-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04940-6","author":"H Chen","year":"2020","unstructured":"Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y et al (2020) Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [(18)F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-04940-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020203275","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, Sun L, Chen H (2021) Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020203275","journal-title":"Radiology"},{"key":"1729_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05494-x","author":"J Kuten","year":"2021","unstructured":"Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, Mishani E, Even-Sapir E (2021) Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-021-05494-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05441-w","author":"D Jiang","year":"2021","unstructured":"Jiang D, Chen X, You Z, Wang H, Zhang X, Li X, Ren S, Huang Q, Hua F, Guan Y, Zhao J, Xie F (2021) Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-021-05441-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05307-1","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, Kessler L, Fendler WP, Lindner T, Koerber SA, Cardinale J, Sennung D, Roehrich M, Debus J, Sathekge M, Haberkorn U, Calais J, Serfling S, Buck AL (2021) Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-021-05307-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109867","author":"E \u015eahin","year":"2021","unstructured":"\u015eahin E, Elbo\u011fa U, \u00c7elen YZ, Sever \u00d6N, \u00c7ay\u0131rl\u0131 YB, \u00c7imen U (2021) Comparison of 68Ga-DOTA-FAPI and 18FDG PET\/CT imaging modalities in the detection of liver metastases in patients with gastrointestinal system cancer. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109867","journal-title":"Eur J Radiol"},{"key":"1729_CR25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.258467","author":"C Qin","year":"2021","unstructured":"Qin C, Shao F, Gai Y, Liu Q, Ruan W, Liu F, Hu F, Lan X (2021) 68Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET\/CT. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.120.258467","journal-title":"J Nucl Med"},{"key":"1729_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693640","author":"H Wang","year":"2021","unstructured":"Wang H, Zhu W, Ren S, Kong Y, Huang Q, Zhao J, Guan Y, Jia H, Chen J, Lu L, Xie F, Qin L (2021) 68Ga-FAPI-04 Versus 18F-FDG PET\/CT in the detection of hepatocellular carcinoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.693640","journal-title":"Front Oncol"},{"key":"1729_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-014-2477-5","author":"P Tabrizian","year":"2014","unstructured":"Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, Sarpel U, Labow DM (2014) Cytoreductive surgery and hyperthermicintraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. https:\/\/doi.org\/10.1007\/s11605-014-2477-5","journal-title":"J Gastrointest Surg"},{"key":"1729_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2007.11.032","author":"A Dirisamer","year":"2009","unstructured":"Dirisamer A, Schima W, Heinisch M, Weber M, Lehner HP, Haller J, Langsteger W (2009) Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET\/MDCT. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2007.11.032","journal-title":"Eur J Radiol"},{"key":"1729_CR29","doi-asserted-by":"publisher","unstructured":"Kim SJ, Lee SW. Diagnostic accuracy of 18F-FDG PET\/CT for detection of peritoneal carcinomatosis: a systematic review and meta-analysis. Br J Radiol. 2018; https:\/\/doi.org\/10.1259\/bjr.20170519","DOI":"10.1259\/bjr.20170519"},{"key":"1729_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05146-6","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, Sun L, Wu H, Lin Q, Chen H (2021) Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-05146-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1729_CR31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/MNM.0b013e328357b2d9","volume":"33","author":"YY Lu","year":"2012","unstructured":"Lu YY, Chen JH, Ding HJ, Chien CR, Lin WY, Kao CH (2012) A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18FFDG PET or PET\/CT. Nucl Med Commun 33(11):1127\u20131133","journal-title":"Nucl Med Commun"},{"issue":"4","key":"1729_CR32","first-page":"199","volume":"99","author":"NG Coburn","year":"2009","unstructured":"Coburn NG (2009) Lymph nodes and gastric cancer. J SurgOncol 99(4):199\u2013206","journal-title":"J SurgOncol"},{"issue":"1","key":"1729_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10120-011-0069-6","volume":"15","author":"R Seevaratnam","year":"2012","unstructured":"Seevaratnam R, Cardoso R, McGregor C et al (2012) How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis Gastric Cancer 15(1):3\u201318","journal-title":"A meta-analysis Gastric Cancer"},{"issue":"5","key":"1729_CR34","first-page":"2490","volume":"29","author":"JM Findlay","year":"2019","unstructured":"Findlay JM, Antonowicz S, Segaran A et al (2019) Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery. EurRadiol 29(5):2490\u20132498","journal-title":"EurRadiol"},{"key":"1729_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04769-z","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, Wei J, Wu S, Zhao L, Luo Z, Lin X, Xie C, Sun L, Lin Q, Wu H (2020) Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-04769-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.237016","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, Rathke H, Winter E, Lindner T, Syed M, Bhatti IA, Herfarth K, Choyke PL, Jaeger D, Haberkorn U, Debus J, Giesel FL (2020) The Role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.119.237016","journal-title":"J Nucl Med"},{"issue":"1","key":"1729_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/bjs.9684","volume":"102","author":"T Kinoshita","year":"2015","unstructured":"Kinoshita T, Kinoshita T, Saiura A, Esaki M, Sakamoto H, Yamanaka T (2015) Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 102(1):102\u2013107","journal-title":"Br J Surg"},{"issue":"1","key":"1729_CR38","first-page":"1","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J ClinOncol 25(1):1\u201342","journal-title":"Int J ClinOncol"},{"issue":"3","key":"1729_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T et al (2019) 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med 60(3):386\u2013392","journal-title":"J Nucl Med"},{"key":"1729_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05095-0","author":"W Guo","year":"2021","unstructured":"Guo W, Pang Y, Yao L, Zhao L, Fan C, Ke J, Guo P, Hao B, Fu H, Xie C, Lin Q, Wu H, Sun L, Chen H (2021) Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET\/CT versus MRI and [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-020-05095-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1729_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/PL00012266","volume":"21","author":"S Guadagni","year":"1997","unstructured":"Guadagni S, Catarci M, Kinoshita T, Valenti M, De Bernardinis G, Carboni M (1997) Causes of death and recurrence after surgery for early gastric cancer. World J Surg 21:434\u2013439","journal-title":"World J Surg"},{"key":"1729_CR42","first-page":"193","volume":"39","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Tomioku M, Nabeshima K, Yasuda S (2014) Clinicopathologic features and clinical outcomes of gastric cancer patients with bone metastasis. Tokai J ExpClin Med 39:193\u2013198","journal-title":"Tokai J ExpClin Med"},{"key":"1729_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF02469472","volume":"13","author":"K Yoshikawa","year":"1983","unstructured":"Yoshikawa K, Kitaoka H (1983) Bone metastasis of gastric cancer. Jpn J Surg 13:173\u2013176","journal-title":"Jpn J Surg"},{"key":"1729_CR44","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5230\/jgc.2014.14.3.164","volume":"14","author":"FP Turkoz","year":"2014","unstructured":"Turkoz FP, Solak M, Kilickap S et al (2014) Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival. J Gastric Cancer 14:164\u2013172","journal-title":"J Gastric Cancer"},{"key":"1729_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3922-0","author":"RK Hernandez","year":"2018","unstructured":"Hernandez RK et al (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3922-0","journal-title":"BMC Cancer"},{"key":"1729_CR46","first-page":"109","volume":"9","author":"M Nozue","year":"2002","unstructured":"Nozue M et al (2002) Treatment and prognosis in colorectal cancer patients with bone metastasis. Oncol Rep 9:109\u2013112","journal-title":"Oncol Rep"},{"key":"1729_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5465-4","author":"F Liu","year":"2016","unstructured":"Liu F et al (2016) Prognostic risk factors in patients with bone metastasis from colorectal cancer. Tumour Biol. https:\/\/doi.org\/10.1007\/s13277-016-5465-4","journal-title":"Tumour Biol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-022-01729-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-022-01729-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-022-01729-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T03:18:07Z","timestamp":1666149487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-022-01729-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1007\/s11307-022-01729-x","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}